参考文献:1.Protsenko SA, Semionova AI, Komarov YI, Aleksakhina SN, Ivantsov AO, Iyevleva AG, Imyanitov EN (2015) BRAF-mutated clear cell sarcoma is sensitive to vemurafenib treatment. Investig New Drugs 33:1136–1143CrossRef 2.Hocar O, Le CA, Berissi S, Terrier P, Bonvalot S, Vanel D, Auperin A, Le Pechoux C, Bui B, Coindre JM, Robert C (2012) Clear cell sarcoma (malignant melanoma) of soft parts: a clinicopathologic study of 52 cases. Dermatol Res Pract 2012:984096PubMed PubMedCentral 3.Wiesner T, He J, Yelensky R, Esteve-Puig R, Botton T, Yeh I, Lipson D, Otto G, Brennan K, Murali R, Garrido M, Miller VA, Ross JS, Berger MF, Sparatta A, Palmedo G, Cerroni L, Busam KJ, Kutzner H, Cronin MT, Stephens PJ, Bastian BC (2014) Kinase fusions are frequent in Spitz tumours and spitzoid melanomas. Nat Commun 5:3116PubMed PubMedCentral
作者单位:Arnaud Uguen (1) (2) (3) (6) Pascale Marcorelles (2) (3) (5) Marc De Braekeleer (1) (3) (4)
1. Inserm, U1078, F-29200, Brest, France 2. Service d’anatomie et cytologie pathologiques, CHRU Brest, F-29220, Brest, France 3. Université Européenne de Bretagne, Rennes, France 6. Department of Pathology, University Hospital Morvan, 5, Avenue Foch, 29609, Brest, France 5. Faculté de Médecine et des Sciences de la Santé Université de Brest, EA4685, F-29200, Brest, France 4. Laboratoire de Cytogénétique et Biologie de la Reproduction, CHRU Brest, F-29220, Brest, France
刊物类别:Medicine
刊物主题:Medicine & Public Health Oncology Pharmacology and Toxicology